A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and Acceptability
Authors:
- Ethel D. WeldEWEthel D. Weld
- Hiwot HiruyHHHiwot Hiruy
- Kate Morrow GuthrieKGKate Morrow Guthrie
- Joseph L. FavaJFJoseph L. Fava
- Sara E. VargasSVSara E. Vargas
- Karen W. BuckheitKBKaren W. Buckheit
- Robert W. BuckheitRBRobert W. Buckheit
- Hans SpiegelHSHans Spiegel
- Jennifer C. BreakeyJBJennifer C. Breakey
- Edward J. FuchsEFEdward J. Fuchs
- Craig W. HendrixCHCraig W. Hendrix
- 1 May 2017
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 33 (5) , 440-447
Abstract
For persons at risk of HIV infection who practice receptive anal intercourse (RAI), topical rectal microbicides represent a promising option for coitally-dependent protection. The study compared colorectal distribution and user sensory experiences of two different volumes of rectal gel for suitability as rectal microbicide. Eight HIV negative men with a history of recent RAI were enrolled into a two-period, sequence randomized, dosing study comparing 3.5 mL and 10 mL of radiolabeled (1 mCi 99mTc-DTPA) universal placebo hydroxyethyl cellulose (HEC) gel. Each participant received two doses in the research unit, one of each volume, separated by a washout period of at least 2 weeks. Each research unit dose was followed by a self-administered take-home dose in the context of preparing for RAI. Safety and gastrointestinal distribution were assessed after the research unit doses; safety, perceptibility, and acceptability were assessed after take-home doses. There were no adverse effects of Grade 2 or higher and all resolved spontaneously. Both volumes were well tolerated and received high acceptability scores. Perceptibility scores showed meaningful effect size differences ranging from Cohen’s d=.5 to d=1.2. The 3.5 mL and 10 mL gel volumes distributed similarly (p>0.2) within the rectosigmoid ranging from 0.69 cm to 18.84 cm and 1.21 cm to 19.01 cm from the anorectal junction, respectively. Both volumes covered the typical gastrointestinal distribution of ejaculate following simulated intercourse based on other studies. Either of these gel volumes could reasonably be pursued for the next phase of development of rectal microbicides.Keywords
This publication has 37 references indexed in Scilit:
- A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)PLOS ONE, 2013
- Quantitative Assessment of Altered Rectal Mucosal Permeability Due to Rectally Applied Nonoxynol-9, Biopsy, and Simulated IntercourseThe Journal of Infectious Diseases, 2013
- Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Colon After Simulated Receptive Anal Intercourse in Men Who Have Sex With MenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- A Case Study in Pharmacologic Colon Imaging Using Principal Curves in Single-Photon Emission Computed TomographyJournal of the American Statistical Association, 2008
- Mucosal Irritation Potential of Personal Lubricants Relates to Product Osmolality as Detected by the Slug Mucosal Irritation AssaySexually Transmitted Diseases, 2008
- Rectal Microbicide Acceptability: Results of a Volume Escalation TrialSexually Transmitted Diseases, 2007
- Hyperosmolar Sexual Lubricant Causes Epithelial Damage in the Distal Colon: Potential Implication for HIV TransmissionThe Journal of Infectious Diseases, 2007
- Colonic range of 5‐ASA enemas in healthy individuals, with a comparison of their physical and chemical characteristics. An open, single‐dose, randomized, cross‐over studyAlimentary Pharmacology & Therapeutics, 1997
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951